DeSimone Jill has filed 6 insider transactions across 2 companies since June 2023.
Most recent transaction: a grant/award of 10520 shares of Praxis Precision Medicines, Inc. ($PRAX) on June 26, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 26, 2025 | Praxis Precision Medicines, Inc. | $PRAX | DeSimone Jill | Director | A | Stock Option (Right to Buy) | 10520 | $0.00 | 10,520.0000 | 20,163,250 | 9999.99% | 0.05% |
| June 11, 2024 | iTeos Therapeutics, Inc. | $ITOS | DeSimone Jill | Not found | A | Stock Option (Right to Buy) | 24200 | $0.00 | 24,200.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | Praxis Precision Medicines, Inc. | $PRAX | DeSimone Jill | Director | A | Stock Option (Right to Buy) | 8566 | $0.00 | 8,566.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2024 | iTeos Therapeutics, Inc. | $ITOS | DeSimone Jill | Not found | A | Stock Option (Right to Buy) | 44766 | $0.00 | 44,766.0000 | 0 | 9999.99% | 0.00% |
| Oct. 5, 2023 | Praxis Precision Medicines, Inc. | $PRAX | DeSimone Jill | Director | P | Common Stock | 14500 | $1.75 | 14,500.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2023 | Praxis Precision Medicines, Inc. | $PRAX | DeSimone Jill | Director | A | Stock Option (Right to Buy) | 28981 | $0.00 | 28,981.0000 | 0 | 9999.99% | 0.00% |